TEVVF.PFD (Teva Pharmaceutical Industries) 5-Year Yield-on-Cost % : 4.93 (As of Dec. 14, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Teva Pharmaceutical Industries 5-Year Yield-on-Cost %?

Teva Pharmaceutical Industries's yield on cost for the quarter that ended in Sep. 2024 was 4.93.

The historical rank and industry rank for Teva Pharmaceutical Industries's 5-Year Yield-on-Cost % or its related term are showing as below:

TEVVF.PFD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.36 Med: 2.33 Max: 9.59
Current: 4.93

During the past 13 years, Teva Pharmaceutical Industries's highest Yield on Cost was 9.59. The lowest was 0.36. And the median was 2.33.

TEVVF.PFD's 5-Year Yield-on-Cost % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.185 vs TEVVF.PFD: 4.93

Competitive Comparison of Teva Pharmaceutical Industries's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's 5-Year Yield-on-Cost % falls into.

Teva Pharmaceutical Industries 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Teva Pharmaceutical Industries is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Teva Pharmaceutical Industries (OTCPK:TEVVF.PFD) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Teva Pharmaceutical Industries 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (OTCPK:TEVVF.PFD) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

TEVJF:USA TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEV:Germany TEV:Germany T1EV34:Brazil TEV:Bulgaria TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.